Erleada and Lantus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Erleada (apalutamide) and Lantus (insulin glargine recombinant). Common drug interactions include diabetic ketoacidosis among males.
The phase IV clinical study analyzes what interactions people have when they take Erleada and Lantus. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Erleada?
Erleada has active ingredients of apalutamide. eHealthMe is studying from 7,519 Erleada users. Check the latest studies of Erleada.
What is Lantus?
Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.
27 people who take Erleada and Lantus together, and have interactions are studied.
What are the common drug interactions of Erleada and Lantus, by gender? *:
female:
n/a
male:
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Fatigue (feeling of tiredness)
- Death
- Diarrhoea
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Urinary tract infection
- Restless legs syndrome (a powerful urge to move your legs)
- Anaemia (lack of blood)
- Blindness
- Blood pressure increased
What are the common drug interactions of Erleada and Lantus, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Urinary tract infection
60+:
- Fatigue (feeling of tiredness)
- Asthenia (weakness)
- Death
- Diarrhoea
- Anaemia (lack of blood)
- Blood pressure increased
- Blood triglycerides increased
- Cardiac disorder
- Drug ineffective
- Eating disorder
What are the existing conditions these people have? *
- Prostate Cancer: 20 people, 74.07%
* Approximation only. Some reports may have incomplete information.
Do you take Erleada and Lantus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Erleada and Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Erleada:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Erleada and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on apalutamide and insulin glargine recombinant (the active ingredients of Erleada and Lantus, respectively), and Erleada and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mobic cause Eczema? - now
- Rizatriptan Benzoate vs. Oxycodone And Acetaminophen, side effect and effectiveness comparison - 2 seconds ago
- Drug interactions of Tizanidine Hydrochloride and Concerta - 7 seconds ago
- Drug interactions of Aminocaproic Acid and Metoprolol Tartrate - 16 seconds ago
- Vyvanse and Nausea Aggravated for Men aged 60+ - 29 seconds ago
- Back Pain and drugs of ingredients of iodixanol - 29 seconds ago
- Could Voltaren cause Pulmonary Tuberculosis? - 38 seconds ago
- Fentanyl and Osteomyelitis for Women aged 60+ - 46 seconds ago
- Carpal Tunnel Syndrome and drugs of ingredients of mirabegron - 54 seconds ago
- Drug interactions of Daptomycin and Solu-Medrol - 56 seconds ago